The Legal Intelligencer | News
By Amanda Bronstad | February 2, 2024
On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered 55 cases filed against Eli Lilly and Novo Nordisk over Ozempic, Mounjaro and other medications be coordinated into multidistrict litigation.
By Charles Toutant | January 29, 2024
On Sept. 12, 2023, the FDA issued a report on phenylephrine, saying that there were no safety issues found with its use as a decongestant but there were also no benefits, the suit said.
By Charles Toutant | January 19, 2024
Courts have consistently rejected challenges under the Takings Clause to federal health care programs that seek to limit costs, according to an amicus curiae brief by a panel of nine nationally recognized experts in Medicare and medical finance.
By Charles Toutant | January 3, 2024
"This disappointing decision is based on legal and factual errors we are confident will be reversed on appeal," Joseph K. Belanoff, Corcept's CEO, said in a statement.
By Colleen Murphy | January 2, 2024
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be the first to know about new suits in your region, practice area or client sector.
By Colleen Murphy | December 20, 2023
"Defendants had actual knowledge of the misrepresentations and/or omissions of material facts set forth herein, or acted with reckless disregard for the truth in that they failed to ascertain and to disclose such facts, even though such facts were available to them," the complaint said.
New Jersey Law Journal | Commentary
By Law Journal Editorial Board | December 17, 2023
However 'Harrington v. Purdue Pharma' is decided, the deal leaves a bad taste.
By Colleen Murphy | December 13, 2023
"Merck later admitted its lawsuit had no merit because it had failed to disclose prior art to the United States Patent and Trademark Office that would have resulted in the denial of patent protection for Zetia," the complaint said. "But simply by initiating the litigation, Merck triggered a 30-month stay, which precluded the Food & Drug Administration from granting final approval of Glenmark's ANDA."
By Amanda Bronstad | December 11, 2023
Peter Mougey, a lead plaintiffs attorney in the opioid multidistrict litigation, said of Suboxone patients: "Their teeth are falling out of their mouths."
By Colleen Murphy | November 20, 2023
This complaint was first surfaced by Law.com Radar.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS